• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类核苷转运体在3'-脱氧-3'-氟胸腺嘧啶摄取中的作用。

The role of human nucleoside transporters in uptake of 3'-deoxy-3'-fluorothymidine.

作者信息

Paproski Robert J, Ng Amy M L, Yao Sylvia Y M, Graham Kathryn, Young James D, Cass Carol E

机构信息

Department of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Ave., Edmonton, Alberta, Canada T6G 1Z2.

出版信息

Mol Pharmacol. 2008 Nov;74(5):1372-80. doi: 10.1124/mol.108.048900. Epub 2008 Jul 31.

DOI:10.1124/mol.108.048900
PMID:18669604
Abstract

3'-Deoxy-3'-fluorothymidine (FLT) is a positron emission tomography (PET) tracer used to identify proliferating tumor cells. The purpose of this study was to characterize FLT transport by human nucleoside transporters (hNTs) and to determine the role of hNTs for FLT uptake in various human cancer cell lines. FLT binding to hNTs was monitored by the inhibitory effects of FLT on [(3)H]uridine uptake in yeast cells producing recombinant hNT proteins. hCNT1 displayed the lowest FLT K(i) value for inhibition of [(3)H]uridine uptake, followed by hCNT3, hENT2, hENT1, and hCNT2. [(3)H]FLT was efficiently transported in Xenopus laevis oocytes individually producing hENT1, hENT2, hCNT1, or hCNT3. [(3)H]FLT uptake in MCF-7, A549, U251, A498, MIA PaCa-2, and Capan-2 cells was inhibited at least 50% by the hENT1 inhibitor nitrobenzylmercaptopurine ribonucleoside (NBMPR). According to results of real-time polymerase chain reactions, hENT1 and hENT2 had the most abundant hNT transcripts in all cell lines. Cell lines also underwent 1) [(3)H]NBMPR equilibrium binding assays with or without 5-S-{2-(1-[(fluorescein-5-yl)thioureido]hexanamido)ethyl}-6-N-(4-nitrobenzyl)-5-thioadenosine, a membrane-impermeable NBMPR analog, to determine plasma membrane hENT1 levels, and 2) dose-response NBMPR inhibition of [(3)H]FLT uptake. MCF-7, A549, and Capan-2 cells displayed NBMPR IC(50) values that were smaller or equal to NBMPR K(d) values, suggesting that 50% inhibition of hENT1 reduced [(3)H]FLT uptake by at least 50%. A strong correlation between extracellular NBMPR binding sites/cell and [(3)H]FLT uptake was observed for all cell lines except MIA PaCa-2. These data suggest that plasma membrane hNTs (especially hENT1) are important determinants of cellular FLT uptake.

摘要

3'-脱氧-3'-氟胸腺嘧啶核苷(FLT)是一种用于识别增殖肿瘤细胞的正电子发射断层扫描(PET)示踪剂。本研究的目的是表征人核苷转运体(hNTs)对FLT的转运,并确定hNTs在各种人类癌细胞系中对FLT摄取的作用。通过FLT对产生重组hNT蛋白的酵母细胞中[³H]尿苷摄取的抑制作用来监测FLT与hNTs的结合。hCNT1对[³H]尿苷摄取抑制的FLT K(i)值最低,其次是hCNT3、hENT2、hENT1和hCNT2。[³H]FLT在单独表达hENT1、hENT2、hCNT1或hCNT3的非洲爪蟾卵母细胞中能有效转运。hENT1抑制剂硝基苄基巯基嘌呤核糖核苷(NBMPR)可使MCF-7、A549、U251、A498、MIA PaCa-2和Capan-2细胞中[³H]FLT的摄取至少抑制50%。根据实时聚合酶链反应结果,hENT1和hENT2在所有细胞系中具有最丰富的hNT转录本。细胞系还进行了1)使用或不使用5-S-{2-(1-[(荧光素-5-基)硫脲基]己酰胺基)乙基}-6-N-(4-硝基苄基)-5-硫代腺苷(一种膜不可渗透的NBMPR类似物)进行[³H]NBMPR平衡结合测定,以确定质膜hENT1水平,以及2)剂量反应性NBMPR对[³H]FLT摄取的抑制作用。MCF-7、A549和Capan-2细胞显示的NBMPR IC(50)值小于或等于NBMPR K(d)值,这表明hENT1的50%抑制至少使[³H]FLT摄取减少50%。除MIA PaCa-2外,所有细胞系均观察到细胞外NBMPR结合位点/细胞与[³H]FLT摄取之间存在强相关性。这些数据表明质膜hNTs(尤其是hENT1)是细胞FLT摄取的重要决定因素。

相似文献

1
The role of human nucleoside transporters in uptake of 3'-deoxy-3'-fluorothymidine.人类核苷转运体在3'-脱氧-3'-氟胸腺嘧啶摄取中的作用。
Mol Pharmacol. 2008 Nov;74(5):1372-80. doi: 10.1124/mol.108.048900. Epub 2008 Jul 31.
2
Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine.用正电子发射断层扫描示踪剂 3'-脱氧-3'-氟胸苷预测人胰腺癌细胞系中的吉西他滨转运和毒性。
Biochem Pharmacol. 2010 Feb 15;79(4):587-95. doi: 10.1016/j.bcp.2009.09.025.
3
Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.ENT1 基因敲除小鼠和 ENT1 基因敲低肿瘤模型中 3'-脱氧-3'-氟胸苷的分布和摄取。
J Nucl Med. 2010 Sep;51(9):1447-55. doi: 10.2967/jnumed.110.076356. Epub 2010 Aug 18.
4
Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney.广泛选择性平衡型和浓缩型核苷转运体hENT1和hCNT3在人肾脏中的定位
Am J Physiol Renal Physiol. 2007 Jul;293(1):F200-11. doi: 10.1152/ajprenal.00007.2007. Epub 2007 Apr 4.
5
Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine.人类核苷转运体在阿扎胞苷和地西他滨摄取及细胞毒性中的作用。
Nucleosides Nucleotides Nucleic Acids. 2012;31(3):236-55. doi: 10.1080/15257770.2011.652330.
6
Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes.通过在蛋白脂质体中进行功能重建,证明培养的人绒毛膜癌细胞(BeWo)核膜中存在平衡核苷转运体(hENT1和hENT2)。
J Biol Chem. 1998 Nov 13;273(46):30818-25. doi: 10.1074/jbc.273.46.30818.
7
Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.缺氧对乳腺癌患者人嘧啶核苷转运蛋白 1(hENT1)和人嘧啶核苷转运蛋白 2(hENT2)的影响。
FASEB J. 2019 Dec;33(12):13837-13851. doi: 10.1096/fj.201900870RR. Epub 2019 Oct 10.
8
Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.吉西他滨在表达重组质膜哺乳动物核苷转运体的非洲爪蟾卵母细胞中的转运
J Natl Cancer Inst. 1999 Nov 3;91(21):1876-81. doi: 10.1093/jnci/91.21.1876.
9
Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside.人核苷转运体在肌苷酸脱氢酶的两种抑制剂(替唑呋林和苯甲酰胺核糖苷)细胞摄取中的作用
Mol Pharmacol. 2005 Jan;67(1):273-9. doi: 10.1124/mol.104.004408. Epub 2004 Oct 14.
10
Expression and functional activity of nucleoside transporters in human choroid plexus.人脉络丛中核苷转运体的表达及功能活性
Cerebrospinal Fluid Res. 2010 Jan 11;7:2. doi: 10.1186/1743-8454-7-2.

引用本文的文献

1
The anti-cancer transition-state inhibitor MTDIA inhibits human MTAP, inducing autophagy in humanized yeast.抗癌过渡态抑制剂MTDIA抑制人源MTAP,在人源化酵母中诱导自噬。
Dis Model Mech. 2025 Jun 1;18(6). doi: 10.1242/dmm.052173. Epub 2025 Jun 30.
2
Cell proliferation detected using [F]FLT PET/CT as an early marker of abdominal aortic aneurysm.使用 [F]FLT PET/CT 检测细胞增殖作为腹主动脉瘤的早期标志物。
J Nucl Cardiol. 2021 Oct;28(5):1961-1971. doi: 10.1007/s12350-019-01946-y. Epub 2019 Nov 18.
3
Demonstration of Nucleoside Transporter Activity in the Nose-to-Brain Distribution of [F]Fluorothymidine Using PET Imaging.
利用 PET 成像研究 [F]氟胸苷经鼻脑分布中的核苷转运体活性。
AAPS J. 2017 Dec 7;20(1):16. doi: 10.1208/s12248-017-0158-5.
4
Early detection of thymidylate synthase resistance in non-small cell lung cancer with FLT-PET imaging.利用FLT-PET成像早期检测非小细胞肺癌中的胸苷酸合成酶耐药性。
Oncotarget. 2017 Jul 31;8(47):82705-82713. doi: 10.18632/oncotarget.19751. eCollection 2017 Oct 10.
5
3'-Deoxy-3'-[F]Fluorothymidine Uptake Is Related to Thymidine Phosphorylase Expression in Various Experimental Tumor Models.3'-脱氧-3'-[F]氟胸苷摄取与各种实验性肿瘤模型中的胸苷磷酸化酶表达相关。
Mol Imaging Biol. 2018 Apr;20(2):194-199. doi: 10.1007/s11307-017-1125-3.
6
Preclinical Applications of 3'-Deoxy-3'-[F]Fluorothymidine in Oncology - A Systematic Review.3'-脱氧-3'-[F]氟胸腺嘧啶在肿瘤学中的临床前应用——一项系统综述
Theranostics. 2017 Jan 1;7(1):40-50. doi: 10.7150/thno.16676. eCollection 2017.
7
Response Monitoring with [F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases.在结直肠癌肝转移实验大鼠模型中,用[F]氟代胸苷正电子发射断层扫描(PET)和扩散加权磁共振成像(MRI)进行细胞毒性5-氟尿嘧啶治疗后的反应监测
Mol Imaging Biol. 2017 Aug;19(4):540-549. doi: 10.1007/s11307-016-1021-2.
8
F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma.F-FLT正电子发射断层扫描(PET)是一种用于评估EWS-FLI1活性和尤因肉瘤的药效学标志物。
Sci Rep. 2016 Sep 27;6:33926. doi: 10.1038/srep33926.
9
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging.利用FLT-PET成像早期检测培美曲塞诱导的非小细胞肺癌中胸苷酸合成酶抑制作用。
Oncotarget. 2017 Apr 11;8(15):24213-24223. doi: 10.18632/oncotarget.12085.
10
Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy.利用放射发光显微镜对¹⁸F-FLT摄取进行单细胞表征
J Nucl Med. 2016 Jul;57(7):1136-40. doi: 10.2967/jnumed.115.167734. Epub 2016 Apr 14.